Assessing real-world effectiveness of therapies: what is the impact of incretin-based treatments on hospital use for patients with type 2 diabetes? Jessica LAUBERT2023-01-24T18:01:40+01:0019/01/2023| Lire la suite
Determinants of the cost-effectiveness of telemedicine: systematic screening and quantitative analysis of the literature Jessica LAUBERT2023-09-07T15:02:16+01:0001/01/2023| Lire la suite
Assessing real-world effectiveness of therapies: what is the impact of incretin-based treatments on hospital use for patients with type 2 diabetes? Jessica LAUBERT2022-12-28T10:48:48+01:0022/10/2022| Lire la suite
One last effort. Are high out‑of‑pocket payments at the end of life a fatality? Jessica LAUBERT2022-08-05T15:31:20+01:0031/01/2022| Lire la suite
